Msc in Economics and Business Administration Master Thesis MSc in Finance Valuation of Pfizer Inc. and analysis of new drug development project using a real option approach. Author: Valdis Cvetkovs Supervisor: Peter Lochte Jorgensen April 2011 Aarhus Abstract This thesis investigates the world’s largest pharmaceutical company Pfizer Inc. from strategic and financial viewpoint in order to determine companies’ fair market value. The external analysis researches industry and global economic situation
Premium Balance sheet Cash flow Generally Accepted Accounting Principles
1. Introduction ........................................................................................................2 2. The stance of Pfizer ............................................................................................3 2.1 Theories of corporate social responsibility and ethics ...................................3 2.2 Pfizer ’s stance on CSR and ethics ..................................................................4 Bribery of Big Pharma ’s ....................
Premium Business ethics Corporate social responsibility Social responsibility
Merck & Co. Executive Summary Case Study Goal The goal of this case study is to examine the current operations of Merck & Co. Inc. and determine areas of potential concern‚ evaluate the effectiveness of the current business model‚ and propose a plan of action to grow Merck & Co. Inc. to be the largest pharmaceutical company in the world. Methods of Analysis This case study will strive to identify areas of concern and opportunity‚ offer solutions‚ and make projections based upon historic data
Premium Financial ratio Financial ratios Strategic management
the way to gain the top spot as the market share leader. Warner-Lambert developed the drug initially but needed to catch up in the market so they teamed up with Pfizer‚ known for their marketing and sales competency. This partnership was just what the doctor ordered for the initial introduction of Lipitor to the market. In 2001‚ Pfizer took full control of Lipitor and changed the marketing game once again. The strategic marketing efforts created competitive advantage for the drug by “delivering
Premium Clinical trial Marketing Pharmaceutical industry
Strategy "We aim to gain leadership positions in key growing therapeutic areas and focus on delivering patient-centric‚ innovative therapies. We seek strong‚ long-term relationships that fit our goals and offer a shared vision “ * Company Background: Pfizer is a research-based global pharmaceutical company. The company discovers‚ develops‚ manufactures and markets medicines for humans and animals‚ as well as consumer products. In order To maximize new opportunities in biomedical research‚ and bring more
Premium Pharmaceutical industry Generic drug
Introduction II. About Lipitor (Atorvastatin) III. Pfizer’s strategy IV. Patients seem to benefit from Pfizer’s new strategy V. Potentially profitable for retailers VI. Pfizer after Lipitor VII. Is Pfizer’s Lipitor strategy working? VIII. Wholesaler Profits: Brand vs. Generic drug IX. Pfizer is hoping to sell Lipitor to consumers over the counter (OTC) X. Discussion XI. References Introduction Lipitor (Atorvastatin)‚ the best-selling
Premium Generic drug Food and Drug Administration Pharmaceutical industry
known as acid-test ratio‚ calculates a company’s cash and accounts receivable divided by its current liabilities. This ratio is a more stringent measure of liquidity than the current ratio in that it excludes inventories and other current assets. Pfizer has a quick ratio of 1.78 while the industry median is 1.21. This shows the company does not rely too much on inventory of other assets to pay for short-term liabilities. The current ratio measures a company’s current assets divided by its current
Premium Asset Balance sheet Generally Accepted Accounting Principles
Neurontin was ineffective and went forward. IV. Through my speech you will learn about Pfizer‚ who committed drug fraud and had to pay hefty fines. A. First‚ I will explain who Pfizer is and what the drug Neurontin does. B. Second‚ I will explain what they have done. C. Finally‚ I will discuss the outcome for Pfizer. Body I. I will explain who Pfizer is and what the drug Neurontin does. A. Pfizer is a pharmaceutical company that is dedicated to discovering and developing new and
Premium Epilepsy
Phyllis Hebert and Sierra Harkness FIN571 February 23‚ 2015 William Stokes Cost of Capital In the Wiley plus simulation (2012)‚ we are introduced to Pfizer‚ the world ’s largest research-based pharmaceutical company‚ Pfizer develops their own pharmaceutical products. Ahmed Singh‚ a consultant accountant who works for the Pfizer Treasury Department‚ explains that his role in the company is "to think and plan ahead for what should be the optimal plan structure for the company" (Wiley Plus
Premium Finance Investment Pharmacology
QUESTION 1 It is only companies that put extra effort and resources into developing‚ training and properly incentivising their workforce that will be able to retain their good staff. Critically discuss how Pfizer‚ with their biggest challenge being “the skills shortage and the retention of talented and skilled staff”‚ attempts to overcome this challenge. 1.1 Introduction The twenty-first century is characterized by businesses that are evolving in a rapidly changing and competitive environment
Premium Human resource management Management